Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 10, 2010 - Issue 3
Submit an article Journal homepage
137
Views
5
CrossRef citations to date
0
Altmetric
Review

The economics of improved cancer survival rates: better outcomes, higher costs

Carin A Uyl-de Groot Institute for Medical Technology Assessment, Institute of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands;[email protected]
,
Saskia de Groot Institute for Medical Technology Assessment, Institute of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands; Institute for Medical Technology Assessment, Institute of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands
&
Adri Steenhoek Institute for Medical Technology Assessment, Institute of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands; Institute for Medical Technology Assessment, Institute of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands
Pages 283-292 | Published online: 09 Jan 2014

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Gerardus WJ Frederix, Johan L Severens & Anke M Hövels. (2015) Use of quality checklists and need for disease-specific guidance in economic evaluations: a meta-review. Expert Review of Pharmacoeconomics & Outcomes Research 15:4, pages 675-685.
Read now

Articles from other publishers (4)

N. van der Linden, C. W. M. van Gils, C. P. Pescott, J. Buter, M. R. Vergeer & C. A. Uyl-de Groot. (2014) Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck. European Archives of Oto-Rhino-Laryngology 272:8, pages 2007-2016.
Crossref
G.W.J. Frederix, J.L. Severens, A.M. Hövels, J.G.C. van Hasselt, M.J.J. Hooiveld, P. Neven, J.A.M. Raaijmakers & J.H.M. Schellens. (2015) Real world cost of human epidermal receptor 2-positive metastatic breast cancer patients: a longitudinal incidence-based observational costing study in the Netherlands and Belgium. European Journal of Cancer Care 24:3, pages 340-354.
Crossref
Paul Cornes. (2012) The economic pressures for biosimilar drug use in cancer medicine. Targeted Oncology 7:S1, pages 57-67.
Crossref
P. Cornes. (2011) The economic pressures for biosimilar drug use in cancer medicineLes pressions économiques en faveur de l’utilisation des biosimilaires en oncologie. Oncologie 13:5, pages 222-233.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.